During development from cervical CIN I to CIN III, the MAPK/ERK pathway is significantly activated [63].The inactivation of ERK1/2 induced by MEK inhibition inhibits tumor cell proliferation and promotes cell apoptosis [64]. The gene discussed is MAP2K7; the disease is uterine cervix carcinoma in situ.